. 2015 Jan 30;36(18):1090–1097. doi: 10.1093/eurheartj/ehv009

Table 1.

Overview of biomarkers analysed in peripartum cardiomyopathy patients

Biomarker	Relevance for PPCM
NT-proBNP	Not specific for PPCM, but good sensitivity for heart failure.^23,39
16-kDa Prolactin	Pathophysiological factor of PPCM, high technical effort for measurement, diagnostic accuracy needs to be evaluated.^37,42
Interferon-γ	Elevated plasma levels in PPCM patients, diagnostic accuracy needs to be evaluated.^39,49
Asymmetric Dimethylarginine (ADMA)	Marker for endothelial dysfunction and cardiovascular risk, diagnostic accuracy needs to be evaluated.²³
Cathepsin D	Activity elevated in plasma of PPCM patients, diagnostic accuracy needs to be further evaluated.^23,37
Soluble fms-like tyrosine kinase-1 (sFlt-1)	Elevated plasma levels in PPCM patients, diagnostic accuracy needs to be further evaluated.³³
microRNA-146a	Pathophysiological factor of PPCM, high technical effort for measurement, diagnostic accuracy needs to be further evaluated.^23,38

PPCM, peripartum cardiomyopathy.